Skip to content
lifestyle.phenomena.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
B. Braun Medical Inc.
Central Admixture Pharmacy Services Announces Sale of 503B Product Portfolio to Quva Pharma
September 8, 2026
B. Braun Announces Approval and Commercialization of First Generic Sugammadex Injection in the U.S. Market
July 14, 2026
B. Braun Launches Rocuronium Bromide Injection in a Room-Temperature-Stable Prefilled Syringe
May 4, 2026